These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9453015)

  • 1. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
    Grønbaek H; Vogel I; Osterby R; Lancranjan I; Flyvbjerg A; Orskov H
    Kidney Int; 1998 Jan; 53(1):173-80. PubMed ID: 9453015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
    Flyvbjerg A; Marshall SM; Frystyk J; Hansen KW; Harris AG; Orskov H
    Kidney Int; 1992 Apr; 41(4):805-12. PubMed ID: 1513103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats.
    Ikeda T; Hoshino T
    Nephron; 1996; 74(4):709-12. PubMed ID: 8956306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats].
    Iwasaki S
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):247-55. PubMed ID: 8501854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats.
    Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
    Am J Kidney Dis; 2000 Aug; 36(2):368-77. PubMed ID: 10922316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
    Nielsen B; Gronbaek H; Osterby R; Orskov H; Flyvbjerg A
    Exp Nephrol; 1999; 7(3):242-50. PubMed ID: 10352365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
    Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
    J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
    Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
    Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
    Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
    Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
    New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
    Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
    Villa E; Rábano A; Cazes M; Cloarec A; Ruilope LM; García-Robles R
    Am J Hypertens; 1997 Mar; 10(3):275-81. PubMed ID: 9056684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
    Lehfeld LS; Silveira LA; Ghini B; Lopes de Faria JB
    Kidney Blood Press Res; 2004; 27(2):114-20. PubMed ID: 15051931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
    Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A
    J Endocrinol; 1995 Oct; 147(1):95-102. PubMed ID: 7490542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats.
    Muntzel M; Hannedouche T; Niesor R; Nöel LH; Souberbielle JC; Lacour B; Drüeke T
    Clin Sci (Lond); 1992 Nov; 83(5):575-81. PubMed ID: 1335394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
    Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
    Akbar DH; Hagras MM; Amin HA; Khorshid OA
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin-induced diabetes.
    Isogai S; Kameyama M; Iso K; Yoshino G
    J Diabetes Complications; 1998; 12(3):170-5. PubMed ID: 9618073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.